The 2024 STI Prevention Conference Recap The 2024 STI Prevention Conference in Atlanta, GA, attracted 1292 attendees, including clinicians, researchers, program staff, advocates, students, industry partners and many others. Aligning with ASTDA’s commitment to workforce development, a third of the participants were early-career professionals. The program had 50 symposium presentations, more than 100 oral presentations, and more than 250 posters! View Recorded Sessions from the Conference

Dear ASTDA Members, We hope this message finds you well. We look forward to seeing you in Chicago at the ISSTDR 2023 meeting in July—a conference that ASTDA is co-sponsoring. We sincerely thank Bobbie Van Der Pol, past ASTDA president, who is organizing the meeting; Lynn Barclay and ASHA, co-sponsors of the meeting; and Drs. Patti Kissinger and Andy Winters for chairing the Scientific Committee. This meeting is the first

The ASTDA Membership Workgroup focuses on the membership composition of the ASTDA. Traditionally, the composition of the Workgroup consisted of at least three members of the Board of Directors with the inclusion of at least one of the early career Board members to represent the views of younger professionals. The current Workgroup members are Lynn Barclay, Khalil Ghanem, Kathy Hsu (chair), Abby Norris Turner, Anne Rompalo, and Lizzi Torrone. A long-term goal of ASTDA

Join the National Center for HIV, Viral Hepatitis, STD, and TB Prevention Position: Medical Officer GP-602-14 Duty Location: Atlanta, GA Application Deadline: December 21, 2022 Application link for external candidates Apply Here: External Candidates Internal CDC Candidates The Clinical, Economic and Health Services Research Branch (CEHSRB), within the Division of STD Prevention (DSTDP), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)

Advancing Policy as a Public Health Intervention NOFO The Centers for Disease Control and Prevention (CDC) has released a Notice of Funding Opportunity (NOFO): Advancing Policy as a Public Health Intervention to Reduce Morbidity, Mortality and Disparities in HIV, Viral Hepatitis, STDs, and Tuberculosis. This NOFO provides funding to conduct robust policy surveillance and legal mapping of priority and emerging policy levers, including cross-cutting syndemic topics (e.g., social determinants of health, infectious disease

ISSTDR Board—Call for Nominations The International Society for Sexually Transmitted Diseases Research (ISSTDR) Board invites nominations for membership on the Board. Nominations will be considered at the ISSTDR Board meeting to be held in June 2023, approximately a month in advance of the STI & HIV World Congress in Chicago from July 24-27, 2023. There will be four positions open on the ISSTDR Board. Successful applicants will have a strong track record in

Dear ASTDA Members, We hope this message finds you well. The monkeypox outbreak has certainly kept many of us busy the last few months. Please don’t forget to focus on your wellbeing during these challenging times. We are delighted to announce the election of the following new members to the ASTDA Board of Directors: Hilary Reno, MD, PhD—Associate Professor at Washington University in St. Louis Elizabeth (Lizzi) Torrone, PhD—Team Lead, Surveillance & Special Studies,

Solicitation of Nominations for Appointment to the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) The Centers for Disease Control and Prevention (CDC) is seeking nominations for membership on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT). The CHACHSPT consists of 18 experts in fields associated with public health; epidemiology; laboratory practice; immunology; infectious diseases; drug abuse; behavioral science; health education; healthcare delivery;

USPSTF Final Recommendation Statement: Screening for Chlamydia and Gonorrhea On September 14, 2021, the U.S. Preventive Services Task Force (USPSTF) released a final recommendation statement on screening for chlamydia and gonorrhea. USPSTF recommends screening for these infections in sexually active women and pregnant people 24 years and younger, or 25 years and older if at increased risk. There is not enough evidence to recommend for or against screening for these infections in men. As

Dear ASTDA Members, We hope this message finds you well. These have been challenging times. Despite the broad availability of vaccines in the United States, the uncertainty about the pandemic’s trajectory weighs heavily on all of us. We hope that you’ve been able to find some balance between the demands of work, and your ability to maintain personal wellness. Since the last update one year ago, Khalil Ghanem has taken over for Bobbie Van